Utah Medical Products appoints director, increases quarterly dividend to $0.31/share

UTAH MEDICAL PRODUCTS INC

Appointed Kevin Timken to board, increasing size to 6; he joins Audit and Compensation committees.
Timken received 10,000 stock options at $58.10, vesting over 4 years; quarterly fee $7,650 pro-rated.
Quarterly cash dividend raised to $0.31 per share, payable Jan 5, 2026 to holders of record Dec 16, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.